Ginseng in Treatment of Fatigue in Multiple Sclerosis
Study of Ginseng in Treatment of Fatigue in Multiple Sclerosis
What it found
The main measure showed a statistically significant benefit.
“Statistical analysis showed better effects for ginseng than the placebo as regards MFIS (p = 0.046) and MSQOL (p ≤ 0.0001) after 3 months.”Read by software from the paper's abstract
3 months
p = 0.046
Total participants: 60
Read by software from the paper's abstract
This trial finished 15 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Ginseng, asian
Placebo
- Placebo
What it measured
Main measures
Fatigue
at 3 months after treatment
Thinking and memoryFatigue
Other measures (1)
Quality Of Life
at 3 months after treatment
Quality of life (reported by participants)
Who could take part
Relapsing MS · 18 to 50
Show the full criteria
Inclusion criteria
* definite diagnosis of relapsing-remitting MS (RRMS) by the MacDonald criteria with a baseline of Expanded Disability Status Score (EDSS)of less than 5.0
Exclusion criteria
* prior use of ginseng or any other tonic agents, glucocorticoids, warfarin, digoxin, aspirin, furosemide, caffeine, ephedra and anti-platelet agents within one month prior to enrollment; * Pregnancy or lactation; * history of renal failure; and, * lack of appropriate adherence to the study protocol.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The purpose of this study was to evaluate the efficacy and safety of Ginseng in treatment of fatigue and Quality of Life of MS patients.
Loading reviews and guidelines…
History
Started
Dec 2010
Main results due
Apr 2011
Finished
Apr 2011